Human Genome Upgrade Alert (HGSI)

Posted in pre-market 
January 27th, 2010

Human Genome Sciences (NASDAQ: HGSI) is trading up 2.6% at $28.25 this morning on an analyst call that is getting surprisingly very little coverage so far when you consider the move this stock has seen.  The biotech and genomics player was started as “Outperform” at RBC Capital with a $38 price target.  The highest target is $40.00, so this is a fairly robust initiation.  At 8:34 AM EST we have only seen 9,200 shares trade hands.  The 52-week range is $0.45 to $32.07 and average volume is 7.8 million shares.


Comments are closed